Add Alzheimer’s drug lecanemab to Canada’s public drug plans, agency says | Page 15 | Unpublished
Hello!
Source Feed: Global News - Canada
Author: Globalnews Digital
Publication Date: July 16, 2026 - 09:35

Stay informed

Add Alzheimer’s drug lecanemab to Canada’s public drug plans, agency says

July 16, 2026
Lecanemab is an antibody that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of the disease. 


Unpublished Newswire

 
Ken Mitchell was a published author of both novels and poetry, a playwright and a professor at the University of Regina’s English department, where he taught creative writing. Mitchell helped create the Saskatchewan Writers' Guild, paving the way for the province's literary community. Those who knew him say it will be a huge loss.
August 9, 2026 - 19:04 | | CBC News - Canada
Mounties in northern Alberta say they’ve found human remains belonging to a 12-year-old Edmonton resident.
August 9, 2026 - 19:03 | | The Globe and Mail